Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide was originally developed to treat type 2 diabetes, with clinical trials showing patients reaching 1.0 mg weekly as a standard therapeutic dose for metabolic control. Today, weight loss patients often require doses between 0.5 mg and 2.4 mg weekly, depending on individual tolerance and treatment goals. Understanding how therapeutic dosing works—and how it differs from marketing claims—helps you make informed decisions about your care.

Understanding Semaglutide Therapeutic Dose Ranges

A therapeutic dose is the amount of medication that produces the desired health benefit in your body. For semaglutide in weight loss treatment, this typically falls between 0.5 mg and 2.4 mg injected once weekly. The exact dose varies based on your metabolism, body composition, insulin sensitivity, and how your GLP-1 receptors respond to the medication. PlexusDx designs individualized protocols because no single 'one-size-fits-all' dose works equally well for every patient.

Clinical evidence from semaglutide trials showed that higher doses correlated with greater weight loss, but also with increased side effects like nausea and gastrointestinal distress. Most patients reach meaningful weight loss results between 1.0 mg and 2.0 mg weekly, though some respond optimally at lower doses due to genetic factors affecting peptide sensitivity. Your PlexusDx provider starts you at a lower dose and increases gradually—a process called titration—to allow your body to adapt and find your personal therapeutic sweet spot.

How Semaglutide Titration Builds to Therapeutic Levels

Titration is the gradual increase of your semaglutide dose over several weeks until you reach your therapeutic dose. PlexusDx typically begins patients at 0.25 mg or 0.5 mg in week one, then increases by 0.25 mg increments every 1–2 weeks depending on side effect tolerance and clinical response. This stepwise approach minimizes nausea, appetite suppression that feels uncomfortable, and other adjustment symptoms while allowing your metabolism to stabilize at each level.

Most patients complete titration in 4–8 weeks and reach their therapeutic maintenance dose by week 8–12 of treatment. Throughout this period, your PlexusDx provider monitors your tolerability, weight loss progress, and any metabolic markers via check-ins and optional lab work. The goal is not to chase the highest possible dose, but to identify the dose that delivers maximum benefit with side effects you can manage long-term.

Why Your Therapeutic Dose May Differ from Others

Individual differences in semaglutide response stem from genetics, body composition, baseline metabolism, and how efficiently your GLP-1 receptors signal hunger and satiety control. Two patients with identical starting weights may reach their therapeutic dose at different levels: one may respond optimally at 1.0 mg weekly, while another requires 2.0 mg to achieve similar metabolic benefit. These differences are not due to 'willpower' or compliance—they reflect real variations in how your body processes and responds to the medication.

PlexusDx offers the Precision Peptide Genetic Test to map your genetic predispositions in 14 metabolic pathways, including key variants like GLP1R rs6923761 and GIPR rs1800437 that influence how effectively semaglutide works in your system. By understanding your genetic peptide profile, your PlexusDx provider can anticipate your likely dose requirements and adjust expectations upfront, reducing trial-and-error approaches and helping you reach therapeutic benefits faster.

Semaglutide Dosing Without Price Escalation at PlexusDx

Many weight loss clinics structure pricing around dose increases, charging more as patients scale from starter doses to higher therapeutic levels. PlexusDx takes a fundamentally different approach: your compounded semaglutide injection starts at $149 per month and remains flat across all therapeutic dose tiers, whether you settle at 0.5 mg, 1.5 mg, or 2.4 mg weekly. This pricing model removes financial barriers to finding your true therapeutic dose and eliminates the financial pressure to stay at suboptimal doses.

PlexusDx medications are compounded at licensed 503A pharmacies, allowing cost-effective production compared to branded alternatives, and these savings pass directly to you. Your dose may increase over time—but your price won't change. This commitment to transparent, flat pricing makes it easier to focus on your clinical outcomes rather than treatment costs, whether you choose semaglutide injection, oral semaglutide, or dual-compound protocols.

Reaching and Maintaining Your Therapeutic Semaglutide Dose

Once you reach your therapeutic dose, the goal shifts from titration to maintenance: staying at the dose that delivers consistent metabolic benefit and weight loss without unmanageable side effects. Most PlexusDx patients maintain their therapeutic dose for 3–6 months before reassessing whether dose adjustments are needed. Some patients find their tolerance improves over time and can tolerate a higher therapeutic dose; others find their optimal dose remains stable indefinitely.

Regular check-ins with your PlexusDx provider ensure your therapeutic dose continues serving your health goals as your body composition and metabolism change over months. If weight loss plateaus or side effects shift, your provider may adjust your dose, combine semaglutide with a complementary therapy like our GLP-Squared dual-compound option, or explore whether genetic insights from the Precision Peptide Test reveal untapped pathways for optimization. The therapeutic dose is not static—it is a dynamic target that evolves with your treatment journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical therapeutic dose of semaglutide for weight loss?

Most weight loss patients reach meaningful results between 0.5 mg and 2.4 mg semaglutide injected once weekly, with many settling into a therapeutic range of 1.0–2.0 mg. Your specific therapeutic dose depends on your genetics, metabolism, and tolerance; PlexusDx helps identify yours through individualized titration and optional genetic testing.

How long does it take to reach a therapeutic dose of semaglutide?

PlexusDx typically guides patients through titration over 4–8 weeks, starting at 0.25–0.5 mg and increasing by 0.25 mg increments every 1–2 weeks until reaching your therapeutic dose. Most patients achieve full therapeutic benefit by week 8–12 of treatment.

Does PlexusDx charge more as my semaglutide dose increases?

No. PlexusDx compounded semaglutide injection starts at $149 per month and remains flat across all therapeutic doses—your dose may go up, but your price won't. This transparent model removes financial barriers to finding your optimal treatment level.

Can the Precision Peptide Genetic Test predict my semaglutide therapeutic dose?

The Precision Peptide Genetic Test maps 14 metabolic pathways and 150+ genetic insights, including GLP1R and GIPR variants that influence semaglutide responsiveness. While it cannot predict your exact dose, it reveals your genetic predispositions to peptide sensitivity, helping your PlexusDx provider anticipate your likely therapeutic range and adjust your titration plan accordingly.

What happens if my therapeutic dose stops working after several months?

If weight loss plateaus at your current therapeutic dose, PlexusDx providers may increase your dose, add a complementary therapy like our GLP-Squared dual-compound injection, or order the Precision Peptide Genetic Test to identify alternative metabolic pathways. Regular check-ins ensure your therapeutic dose continues evolving with your body's changing needs.

Is semaglutide from PlexusDx FDA-approved?

PlexusDx semaglutide is compounded at licensed 503A pharmacies under strict pharmaceutical standards, though compounded medications are not FDA-approved in the same way as branded drugs. Semaglutide itself is an FDA-approved active pharmaceutical ingredient; compounding allows personalized dosing at lower cost while maintaining safety and quality.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves